<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Puerperal uterine inversion</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Puerperal uterine inversion</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Puerperal uterine inversion</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">George Macones, MD, MSCE</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Vincenzo Berghella, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Vanessa A Barss, MD, FACOG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 20, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Uterine inversion occurs when the uterine fundus collapses into the endometrial cavity, turning the uterus partially or completely inside out. Although a rare complication of vaginal or cesarean birth, it is a life-threatening obstetric emergency because, if not promptly recognized and treated, uterine inversion can lead to severe hemorrhage and shock, resulting in maternal death.</p><p>This topic will discuss the clinical features, diagnosis, and management of puerperal uterine inversion. Spontaneous inversion of the nonpuerperal uterus accounts for approximately 5 percent of all uterine inversions and will not be addressed here [<a href="#rid1">1</a>]. It is almost always associated with a polypoid uterine tumor, usually a leiomyoma, but other tumors (eg, teratoma, sarcoma) have also been implicated [<a href="#rid2">2-5</a>]. (See  <a class="medical medical_review" href="/z/d/html/3295.html" rel="external">"Uterine fibroids (leiomyomas): Prolapsed fibroids", section on 'Complications'</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">CLASSIFICATION</span><span class="headingEndMark"> — </span>Uterine inversions are classified by the extent of inversion and time of occurrence. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Extent of inversion</strong>  (<a class="graphic graphic_figure graphicRef94756" href="/z/d/graphic/94756.html" rel="external">figure 1</a>)<strong> </strong>[<a href="#rid6">6-9</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>1<sup>st</sup> degree (incomplete inversion) – Fundus within the endometrial cavity</p><p class="bulletIndent2"><span class="glyph">•</span>2<sup>nd</sup> degree (complete inversion) – Fundus protrudes through the cervical os</p><p class="bulletIndent2"><span class="glyph">•</span>3<sup>rd</sup> degree (prolapsed inversion) – Fundus protrudes to or beyond the introitus</p><p class="bulletIndent2"><span class="glyph">•</span>4<sup>th</sup> degree (total inversion) – Both the uterus and vagina are inverted</p><p></p><p class="bulletIndent2">In a review of 358 cases of puerperal uterine inversion, approximately 90 percent were 2nd degree or more [<a href="#rid10">10</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Time of occurrence</strong> [<a href="#rid11">11</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Acute – Within 24 hours of delivery</p><p class="bulletIndent2"><span class="glyph">•</span>Subacute – More than 24 hours but less than four weeks postpartum</p><p class="bulletIndent2"><span class="glyph">•</span>Chronic – ≥1 month postpartum</p><p></p><p class="bulletIndent2">In a review of 229 cases of puerperal uterine inversion, 83.4 percent were acute, 13.9 percent were chronic, and 2.6 percent were subacute [<a href="#rid1">1</a>]. </p><p></p><p class="headingAnchor" id="H3"><span class="h1">INCIDENCE</span><span class="headingEndMark"> — </span>Incidence ranges from 1 in 3500 to 20,000 deliveries [<a href="#rid7">7,12,13</a>]. This wide range may be related to differences in definition of inversion, patient populations, case ascertainment, routine obstetric procedures, and postpartum care. The incidence in the United States was 1 in 3500 deliveries between 2004 and 2013 and appeared to be stable; more recent data are not available [<a href="#rid7">7</a>].</p><p class="headingAnchor" id="H4"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>The pathogenesis of uterine inversion is incompletely understood. It has been attributed to use of excessive cord traction and fundal pressure (Credé maneuver) during the third stage of labor, especially in the setting of uterine atony with fundal placental implantation [<a href="#rid8">8</a>]. However, evidence is inconsistent, and a causal relationship between management of the third stage and puerperal uterine inversion is unproven [<a href="#rid14">14</a>]. It is likely that other factors play a role since spontaneous inversions occur and inversion is rare even though cord traction and the Credé maneuver are commonly performed.</p><p>Hemorrhage may occur because the invaginated fundus may not contract normally and the inverted endometrium is stretched, which exacerbates bleeding from any areas of placental separation.</p><p class="headingAnchor" id="H7109044"><span class="h1">RISK FACTORS</span><span class="headingEndMark"> — </span>In the largest series of puerperal uterine inversion, which included 2427 cases, statistically significant risk factors were abnormal placentation such as retained and/or abnormally adherent placenta (153 cases, adjusted OR 13.6, 95% CI 11.5-16.1), prolonged labor (32 cases, adjusted OR 1.58, 95% CI 1.12-2.25), and preeclampsia with severe features (102 cases, adjusted OR 2.43, 95% CI 1.98-2.98) [<a href="#rid7">7</a>]. The association with preeclampsia was unexpected and unexplained. Multifetal pregnancy appeared to be protective (&lt;10 cases, adjusted OR 0.17, 95% CI 0.07-0.37), but this finding may have been related to the small number of cases.</p><p class="headingAnchor" id="H5"><span class="h1">CLINICAL FEATURES</span></p><p class="headingAnchor" id="H7109293"><span class="h2">Patient presentation</span><span class="headingEndMark"> — </span>Puerperal uterine inversion can follow vaginal or cesarean birth; the latter includes inversion through the hysterotomy incision [<a href="#rid12">12,15</a>]. The clinical presentation depends on the extent and time of occurrence of the inversion. Signs and symptoms include one or more of the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Mild to severe vaginal bleeding</p><p class="bulletIndent1"><span class="glyph">●</span>Mild to severe lower abdominal pain</p><p class="bulletIndent1"><span class="glyph">●</span>A smooth, round mass protruding from the cervix or vagina</p><p class="bulletIndent1"><span class="glyph">●</span>Urinary retention</p><p></p><p>The most common presentation is 2<sup>nd</sup> degree/complete uterine inversion (fundus protrudes through the cervical os) accompanied by severe postpartum hemorrhage, often leading to hypovolemic shock. Shock out of proportion to blood loss has also been described and attributed to increased vagal tone from stretching of the pelvic parasympathetic nerves (neurogenic shock), but this is controversial and may just reflect underestimation of blood loss [<a href="#rid16">16</a>]. On vaginal examination, the inverted fundus fills the vagina. Providers may initially misdiagnose this finding as a protruding fibroid; however, on transabdominal palpation, the uterine fundus is absent from its expected periumbilical position. </p><p>With 3<sup>rd</sup> degree (fundus to or beyond the introitus) and 4<sup>th</sup> degree (uterus and vagina inverted) cases, the protruding uterus is grossly evident on inspection of the perineum.</p><p>First-degree/incomplete uterine inversion is associated with more subtle findings [<a href="#rid7">7,10</a>]. Blood loss may be minimal. Examination through the dilated cervix may reveal a mass (ie, fundus) in the uterine cavity. On abdominal examination, a cup-like defect (fundal notch) may be palpated in the area of the normally globular fundus. In the absence of heavy bleeding or careful examination of the fundus, these patients may not be identified for days or weeks. In such cases, the uterus may become edematous and infected and surgical intervention is likely to be required to replace the uterus because of normal postpartum cervical constriction.</p><p class="headingAnchor" id="H7109096"><span class="h2">Imaging</span><span class="headingEndMark"> — </span>Ultrasound examination of uterine inversion shows the absence of the normal uterine fundal contour and a homogeneous globular mass (ie, inverted fundus) within the uterus [<a href="#rid17">17,18</a>].</p><p class="headingAnchor" id="H7109086"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of acute uterine inversion should be suspected in postpartum patients with hypotension out of proportion to estimated blood loss and/or when the provider is unable to palpate a normally positioned fundus on abdominal examination. Vaginal bleeding potentially resulting in shock and lower abdominal pain are supportive findings. </p><p>The diagnosis is confirmed when the fundus is seen protruding through the cervix or vaginal opening or when transcervical examination finds the fundus inside the uterine cavity and transabdominal examination finds a cup-like defect in the area of the normally globular fundus. (See <a class="local">'Patient presentation'</a> above.)</p><p>Radiographic imaging (eg, ultrasound, magnetic resonance) is rarely necessary, but has been used to confirm inversion when the diagnosis was uncertain and the patient was hemodynamically stable [<a href="#rid17">17</a>]. Importantly, in patients with significant vaginal bleeding, treatment should not be delayed for radiologic confirmation.</p><p class="headingAnchor" id="H6"><span class="h2">Differential diagnosis</span><span class="headingEndMark"> — </span>The most common disorder in differential diagnosis is a prolapsed fibroid. Physical and ultrasonographic examination of the fundus help to distinguish the two disorders: the fundus is usually normal in contour and position with a prolapsed fibroid, whereas with uterine inversion the fundus is absent from its normal position or markedly abnormal (eg, cupped and smaller than expected). (See  <a class="medical medical_review" href="/z/d/html/3295.html" rel="external">"Uterine fibroids (leiomyomas): Prolapsed fibroids"</a>.)</p><p class="headingAnchor" id="H7"><span class="h1">MANAGEMENT</span><span class="headingEndMark"> — </span>The management of puerperal uterine inversion is based on clinical experience described in case reports and small retrospective case series, as well as good clinical judgment. No randomized trials have been performed.</p><p class="headingAnchor" id="H7110949"><span class="h2">Goals</span></p><p class="bulletIndent1"><span class="glyph">●</span>Replace the uterine fundus to its correct position</p><p class="bulletIndent1"><span class="glyph">●</span>Manage postpartum hemorrhage and shock, if present</p><p class="bulletIndent1"><span class="glyph">●</span>Prevent recurrent inversion</p><p></p><p class="headingAnchor" id="H8"><span class="h2">Initial interventions</span><span class="headingEndMark"> — </span>Interventions for the management of acute uterine inversion should begin promptly and simultaneously. A delay in diagnosis or prompt initiation of treatment increases the risk of maternal morbidity and mortality. We suggest:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Discontinue uterotonic drugs</strong> since uterine relaxation is needed to replace the uterine fundus.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Call for immediate assistance</strong>, including anesthesiology staff, additional obstetric staff (and where appropriate, more experienced obstetric staff), and operating room personnel. The patient may require transfer from a labor room to an operating room if manual replacement of the uterus is unsuccessful.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Establish adequate intravenous access and aggressive fluid/blood product resuscitation</strong>. We suggest placing two large bore intravenous lines (eg, at least one intravenous catheter should be 16-gauge) and infusing crystalloid to support blood pressure. Draw blood for baseline laboratory tests, including a complete blood count and coagulation studies (fibrinogen concentration, prothrombin time, activated partial thromboplastin time). Blood products are administered, as needed, to treat hypovolemia and prevent cardiovascular collapse, and reverse coagulopathy, if present. Activate your institutional massive transfusion protocol, as needed. (See  <a class="medical medical_review" href="/z/d/html/6710.html" rel="external">"Overview of postpartum hemorrhage"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Do not remove the placenta</strong>. (See <a class="local">'Management of the placenta'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Immediately attempt to manually replace the inverted uterus</strong> <strong>to its normal position</strong>. This is best accomplished by placing a hand inside the vagina and pushing the fundus along the long axis of the vagina toward the umbilicus (Johnson maneuver)  (<a class="graphic graphic_figure graphicRef94746" href="/z/d/graphic/94746.html" rel="external">figure 2</a>). Prompt intervention is critical since the lower uterine segment and cervix will contract over time and create a constriction ring, thereby making manual replacement progressively more difficult.</p><p></p><p class="bulletIndent1">If a constriction ring is palpable, apply pressure to the part of the fundus nearest the ring to ease it through from bottom to top. This avoids attempting to push a wider diameter of the fundal mass through the ring, which is likely to fail.</p><p></p><p class="bulletIndent1">Attempts at manual replacement may be accompanied by severe bleeding [<a href="#rid19">19</a>].</p><p></p><p class="bulletIndent1">Immediate uterine replacement is unsuccessful was one-third of cases in one series [<a href="#rid20">20</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hemodynamically unstable patients</strong> – After an initial unsuccessful manual attempt at replacement, proceeding directly to laparotomy is reasonable when the patient is hemodynamically unstable.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hemodynamically stable patients</strong> – After an initial unsuccessful manual attempt at replacement in a hemodynamically stable patient, administer uterine relaxants then reattempt manual replacement. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">Nitroglycerin</a> (glyceryl trinitrate) is an excellent uterine relaxant [<a href="#rid21">21</a>]; we suggest 50 micrograms administered intravenously, followed by up to four additional doses of 50 micrograms, as needed to achieve adequate uterine relaxation for replacement. Nitroglycerin has an extremely short half-life [<a href="#rid22">22</a>], which could be advantageous in patients with severe hemorrhage and hemodynamic instability.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="9977" href="/z/d/drug information/9977.html" rel="external">Terbutaline</a> (0.25 milligrams intravenously or subcutaneously) or <a class="drug drug_general" data-topicid="9585" href="/z/d/drug information/9585.html" rel="external">magnesium sulfate</a> (4 to 6 grams intravenously over 15 to 20 minutes) are other options for uterine relaxation. Magnesium sulfate has a slow onset of action, both drugs have relatively mild effects on the myometrium, but both are acceptable if other agents are not available or if the practitioner is unfamiliar with their use.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Inhalational anesthetic agents, such as <a class="drug drug_general" data-topicid="9887" href="/z/d/drug information/9887.html" rel="external">sevoflurane</a>, <a class="drug drug_general" data-topicid="8891" href="/z/d/drug information/8891.html" rel="external">desflurane</a>, and <a class="drug drug_general" data-topicid="8992" href="/z/d/drug information/8992.html" rel="external">isoflurane</a>, are also excellent uterine relaxants and may allow uterine replacement without surgical intervention [<a href="#rid23">23</a>]. Halothane and enflurane are also effective, but these drugs are not used in adults in the United States because of concerns about serious side effects (eg, halothane-related hepatotoxicity), but may be used in some countries with limited resources because of their low cost. The use of all of these drugs requires controlling the maternal airway (intubation). Therefore, inhalational anesthetic agents are best administered in the operating room as an initial step before proceeding to laparotomy for correction of an otherwise refractory uterine inversion. (See <a class="local">'Preferred secondary interventions'</a> below.)</p><p></p><p class="headingAnchor" id="H9"><span class="h2">Preferred secondary interventions</span><span class="headingEndMark"> — </span>If the above measures to replace the uterus fail, then the patient should be taken promptly to the operating room to attempt surgical correction of the inversion.</p><p>At laparotomy, in place of the uterus, a constriction ring containing a dimple or cup or slit is often observed, and the adnexa (fallopian tubes, round ligaments, and possibly one or both ovaries) are typically pulled into this hole. </p><p>We prefer to start with the Huntington procedure because it is less invasive than incision of the constriction ring.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Huntington procedure</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Locate the cup formed by the inversion </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Place a clamp, such as an Allis or Babcock clamp, on each round ligament entering the cup, approximately 2 cm deep in the cup. Clamp the myometrium if the round ligaments cannot be identified. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Gently pull on the clamps to exert upward traction on the inverted fundus  (<a class="graphic graphic_figure graphicRef94745" href="/z/d/graphic/94745.html" rel="external">figure 3</a>) [<a href="#rid19">19,24</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Repeatedly clamp in 2 cm increments along the ligament and exert traction until the inversion is corrected. This procedure is similar to the hand-over-hand movements used when pulling up an anchor line. </p><p></p><p class="bulletIndent1">If available, a second operator can place a hand in the vagina and apply upward pressure on the fundus to facilitate the procedure, or they can pull one of the clamps while the first operator pulls the other clamp.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Haultain procedure</strong> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Make an incision (approximately 1.5 inches in length) in the posterior surface of the uterus to transect the constriction ring and thus increase the size of the previously constricted area  (<a class="graphic graphic_figure graphicRef94758" href="/z/d/graphic/94758.html" rel="external">figure 4</a>) [<a href="#rid25">25,26</a>]. Surgical release of the constriction ring should allow manual reduction of the uterine inversion. We prefer a posterior incision to an anterior incision (Ocejo incision) to reduce the risk of accidental cystotomy.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Manual reduction can be performed through the vagina or by placing a finger abdominally through the myometrial incision to below the fundus and then exerting pressure on the fundus to reduce the inversion. Alternatively, the inversion can be corrected using the Huntington procedure, as described above. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The incision is repaired when the uterus has been returned to a normal position.</p><p></p><p class="headingAnchor" id="H1561518076"><span class="h2">Other options</span><span class="headingEndMark"> — </span>Further investigation of safety and efficacy of these other options are needed before they can be recommended.</p><p class="bulletIndent1"><span class="glyph">●</span>Hydrostatic reduction of acute uterine inversion is an option if initial nonsurgical interventions have failed and surgical intervention is not possible [<a href="#rid27">27-29</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The patient is placed in reversed Trendelenburg lithotomy position.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A bag of warmed fluid is hung at least one meter above the patient and allowed to flow by gravity or with light pressure through tubing connected to a silastic ventouse cup in the vagina; the seal between the perimeter of the cup and the vagina prevents significant leakage. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The resulting intravaginal hydrostatic pressure may force the inverted fundus back to its normal position  (<a class="graphic graphic_figure graphicRef94757" href="/z/d/graphic/94757.html" rel="external">figure 5</a>). Two to 5 liters of fluid may be needed. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A few cases of successful laparoscopic-assisted reduction of acute and chronic uterine inversion have been reported [<a href="#rid30">30-32</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A case report described inserting a vacuum cup into the inverted uterus at laparotomy, creating negative pressure, and then applying gentle traction to reduce the inversion [<a href="#rid33">33</a>].</p><p></p><p class="headingAnchor" id="H2358745625"><span class="h2">Procedures to avoid</span><span class="headingEndMark"> — </span>Vaginal surgical approaches are no longer performed and are potentially dangerous. </p><p class="headingAnchor" id="H10"><span class="h2">Management of the placenta</span><span class="headingEndMark"> — </span>The author’s preference is to not remove the placenta until the uterus has been replaced. Removing the placenta before replacing the uterus increases blood loss, which may be severe [<a href="#rid13">13,34</a>]. Leaving the placenta in situ rarely interferes with the operator's ability to restore the uterus to its normal position, provided that the patient has appropriate anesthesia. After the uterus has been replaced, the most conservative approach is to await spontaneous separation of the placenta, reserving manual extraction for usual obstetric indications (eg, hemorrhage, prolonged third stage).</p><p>Alternatively, the clinician may attempt manual removal, provided that the patient has appropriate anesthesia and is hemodynamically stable. It should be performed in an operating room so that surgical intervention can be undertaken if complications occur. </p><p class="bulletIndent1"><span class="glyph">●</span>Place a hand into the vagina, through the cervix, and into the uterine cavity. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Develop a cleavage plane between the placenta and uterine wall. The operator's hand should eventually be positioned under and cephalad to the placenta so that it can be extracted within their cupped hand, rather than by pulling on a portion of the tissue, which might break off during the extraction. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If placental extraction cannot be accomplished easily, or if bleeding increases, a repeat attempt can be supplemented with sponge-stick or suction curettage. </p><p></p><p>If the placenta remains attached, the possibility of placenta accreta spectrum should be considered. Risk factors, diagnosis, and treatment of placenta accreta are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6759.html" rel="external">"Placenta accreta spectrum: Clinical features, diagnosis, and potential consequences"</a>.)</p><p class="headingAnchor" id="H11"><span class="h2">Management after correction of inversion</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hold the uterus in place</strong> – After the uterus has been replaced, the fundus should be held in place and then monitored until the surgeon is sure that the uterus is firm and its position is stable. The fundus can be held in place with the clinician's hand(s) placed internally, externally, or both.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Administer uterotonic drugs</strong> – Atony is common after restoration of the normal uterine position. Once placental removal has been successfully accomplished, uterotonic agents are administered to induce myometrial contraction and maintain uterine involution, thereby impeding reinversion and reducing the risk of hemorrhage.</p><p></p><p class="bulletIndent1">An <a class="drug drug_general" data-topicid="9734" href="/z/d/drug information/9734.html" rel="external">oxytocin</a> infusion (20 to 40 units in 1 liter of crystalloid infused at 150 to 200 mL per hour) is titrated to keep the uterus contracted. Other options, which can be administered with or without concomitant oxytocin, include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="9203" href="/z/d/drug information/9203.html" rel="external">Carboprost tromethamine</a> (15-methyl prostaglandin F2 alpha) 250 mcg intramuscularly, may be repeated every 15 to 90 minutes for a maximum of eight doses (total cumulative dose 2 mg).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="9657" href="/z/d/drug information/9657.html" rel="external">Misoprostol</a> 800 to 1000 micrograms vaginally. Rectal administration is also acceptable, especially if there is heavy vaginal bleeding.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="9368" href="/z/d/drug information/9368.html" rel="external">Dinoprostone</a> 20 mg (one suppository) vaginally or rectally.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="9637" href="/z/d/drug information/9637.html" rel="external">Methylergonovine</a> 200 mcg intramuscularly every two to six hours for a maximum of four doses.</p><p></p><p class="bulletIndent1">Reactive airway disease is a contraindication to the use of prostaglandin F analogues and <a class="drug drug_general" data-topicid="9637" href="/z/d/drug information/9637.html" rel="external">methylergonovine</a>. Poorly controlled hypertension is also a contraindication to use of methylergonovine.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Antibiotic prophylaxis</strong> – We favor administration of a single dose of a first-generation cephalosporin (eg, <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">cefazolin</a>) for endometritis prophylaxis, provided that the patient does not have a penicillin allergy. In patients with true penicillin allergy, we would use a single dose of <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">clindamycin</a> and <a class="drug drug_general" data-topicid="8489" href="/z/d/drug information/8489.html" rel="external">gentamicin</a> to cover Gram-positive, Gram-negative and anaerobic bacteria. Studies have reported inconsistent data on the efficacy of antibiotic prophylaxis in this setting [<a href="#rid35">35-37</a>]. Infection, which may be severe, has been described in nonacute uterine inversion [<a href="#rid38">38-40</a>]. </p><p></p><p class="headingAnchor" id="H96351563"><span class="h2">Reinversion</span><span class="headingEndMark"> — </span>The treatment of reinversion is similar to that for the initial inversion. In a single case report, an abdominal cerclage was placed to prevent reinversion in a patient with chronic recurrent inversion [<a href="#rid41">41</a>]. In other case reports, an intrauterine balloon [<a href="#rid42">42</a>] or uterine compression sutures were placed to treat postpartum hemorrhage and prevent recurrent uterine inversion [<a href="#rid43">43-45</a>]. </p><p>As an example, the Matsubara-Yano compression suture consists of two longitudinal sutures and two transverse sutures: the longitudinal compression sutures extend from the lower uterine segment to the fundus and penetrate the fundal edge; the transverse compression sutures are placed perpendicular to and across the longitudinal sutures to prevent them from sliding off or migrating to the middle of the uterine fundus  (<a class="graphic graphic_figure graphicRef95455" href="/z/d/graphic/95455.html" rel="external">figure 6</a>) [<a href="#rid45">45</a>]. (See  <a class="medical medical_review" href="/z/d/html/4440.html" rel="external">"Postpartum hemorrhage: Use of an intrauterine hemorrhage-control device"</a> and  <a class="medical medical_review" href="/z/d/html/6712.html" rel="external">"Postpartum hemorrhage: Management approaches requiring laparotomy", section on 'Atony'</a>.)</p><p class="headingAnchor" id="H1003708162"><span class="h1">OUTCOME</span><span class="headingEndMark"> — </span>In a series of 2427 cases of puerperal uterine inversion in the United States, the types and frequencies of complications were [<a href="#rid7">7</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Postpartum hemorrhage (37.7 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Blood transfusion (22.4 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Need for laparotomy (6.0 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Hysterectomy (2.8 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Hypotension (2.1 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Shock (1.3 percent) </p><p class="bulletIndent1"><span class="glyph">●</span>Death (one patient) </p><p></p><p class="headingAnchor" id="H12"><span class="h1">RECURRENCE IN FUTURE PREGNANCY</span><span class="headingEndMark"> — </span>The risk of recurrence of uterine inversion in a future pregnancy is not well-defined. In a series of 40 cases of acute postpartum uterine inversion, there were no recurrences in 26 subsequent deliveries [<a href="#rid12">12</a>].</p><p class="headingAnchor" id="H1566678280"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/113173.html" rel="external">"Society guideline links: Delivery"</a>.)</p><p class="headingAnchor" id="H13"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>General principles</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Clinical significance</strong> – Uterine inversion is a rare complication of vaginal birth, and an obstetric emergency. If not promptly recognized and treated, it can lead to severe hemorrhage and shock, resulting in maternal death. (See <a class="local">'Patient presentation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Classification</strong> – Uterine inversions are classified in terms of the extent and timing of the inversion. Most inversions are acute and complete. (See <a class="local">'Classification'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Etiology</strong> – Uterine inversion has been attributed to excessive cord traction and fundal pressure (Credé maneuver) during the third stage of labor, especially in the setting of a uterine atony and fundal implantation of the placenta. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Diagnosis</strong> – The diagnosis should be suspected in postpartum patients with hypotension out of proportion to estimated blood loss and/or when the provider is unable to palpate a normally positioned fundus on abdominal examination. Vaginal bleeding potentially resulting in shock and lower abdominal pain are supportive findings. The diagnosis is confirmed when the fundus is seen protruding through the cervix or vaginal opening or when transcervical examination finds the fundus inside the uterine cavity and transabdominal examination finds a cup-like defect in the area of the normally globular fundus. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Algorithm  (<a class="graphic graphic_algorithm graphicRef94755" href="/z/d/graphic/94755.html" rel="external">algorithm 1</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Initial interventions</strong> – Initial interventions for management of uterine inversion should be applied rapidly: summon help, discontinue uterotonic drugs, administer crystalloid aggressively and blood products (as needed), and attempt to manually reposition the uterus by pushing the fundus cephalad along the long axis of the vagina. (See <a class="local">'Initial interventions'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Management of the placenta</strong> – If the placenta is attached to an inverted uterus, we suggest leaving it in place rather than extracting it before replacing the uterus (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). Placental extraction may increase hemorrhage. (See <a class="local">'Management of the placenta'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Refractory cases</strong></p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Uterine relaxant</strong> – If the initial attempt at manual uterine replacement is unsuccessful and the patient is hemodynamically stable, we administer a uterine relaxant and reattempt reduction of the inversion. We suggest <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">nitroglycerin</a> over other uterine relaxants (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). It is highly effective and has a short duration of action. However, if the patient is hemodynamically unstable after an initial attempt at replacement, it is reasonable to proceed directly to laparotomy. (See <a class="local">'Management'</a> above and <a class="local">'Initial interventions'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Surgery</strong> – Surgical intervention is required if manual replacement remains unsuccessful after administering a uterine relaxant. We suggest the Huntington rather than the Haultain procedure (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>), given the former does not require incising the uterus. (See <a class="local">'Preferred secondary interventions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Post-uterine replacement management</strong> – A uterotonic agent is administered after uterine replacement to induce myometrial contraction, maintain uterine involution, and prevent reinversion. We use <a class="drug drug_general" data-topicid="9734" href="/z/d/drug information/9734.html" rel="external">oxytocin</a> because of its rapid action, short half-life, familiarity to personnel on labor and delivery units, and relative lack of side effects in virtually all patients. However, any standard uterotonic drug is acceptable, provided there are no medical contraindications to its use, such as hypertension (<a class="drug drug_general" data-topicid="9637" href="/z/d/drug information/9637.html" rel="external">methylergonovine</a>) or reactive airway disease (carboprost). In the absence of any medical contraindications, we suggest, in order of preference, oxytocin, carboprost (Hemabate), or <a class="drug drug_general" data-topicid="9657" href="/z/d/drug information/9657.html" rel="external">misoprostol</a> (Cytotec), and we employ methylergonovine and/or <a class="drug drug_general" data-topicid="9368" href="/z/d/drug information/9368.html" rel="external">dinoprostone</a> as second-line agents. (See <a class="local">'Management after correction of inversion'</a> above.)</p><p></p><p class="headingAnchor" id="H2996282454"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges John T Repke, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Dali SM, Rajbhandari S, Shrestha S. Puerperal inversion of the uterus in Nepal: case reports and review of literature. J Obstet Gynaecol Res 1997; 23:319.</a></li><li><a class="nounderline abstract_t">Lupovitch A, England ER, Chen R. Non-puerperal uterine inversion in association with uterine sarcoma: case report in a 26-year-old and review of the literature. Gynecol Oncol 2005; 97:938.</a></li><li><a class="nounderline abstract_t">Gomez-Lobo V, Burch W, Khanna PC. Nonpuerperal uterine inversion associated with an immature teratoma of the uterus in an adolescent. Obstet Gynecol 2007; 110:491.</a></li><li><a class="nounderline abstract_t">Occhionero M, Restaino G, Ciuffreda M, et al. Uterine inversion in association with uterine sarcoma: a case report with MRI findings and review of the literature. Gynecol Obstet Invest 2012; 73:260.</a></li><li><a class="nounderline abstract_t">Hu CF, Lin H. Ultrasound diagnosis of complete uterine inversion in a nulliparous woman. Acta Obstet Gynecol Scand 2012; 91:379.</a></li><li><a class="nounderline abstract_t">Pauleta JR, Rodrigues R, Melo MA, Graça LM. Ultrasonographic diagnosis of incomplete uterine inversion. Ultrasound Obstet Gynecol 2010; 36:260.</a></li><li><a class="nounderline abstract_t">Coad SL, Dahlgren LS, Hutcheon JA. Risks and consequences of puerperal uterine inversion in the United States, 2004 through 2013. Am J Obstet Gynecol 2017; 217:377.e1.</a></li><li><a class="nounderline abstract_t">Lipitz S, Frenkel Y. Puerperal inversion of the uterus. Eur J Obstet Gynecol Reprod Biol 1988; 27:271.</a></li><li><a class="nounderline abstract_t">Hostetler DR, Bosworth MF. Uterine inversion: a life-threatening obstetric emergency. J Am Board Fam Pract 2000; 13:120.</a></li><li><a class="nounderline abstract_t">Morini A, Angelini R, Giardini G. [Acute puerperal uterine inversion: a report of 3 cases and an analysis of 358 cases in the literature]. Minerva Ginecol 1994; 46:115.</a></li><li><a class="nounderline abstract_t">Livingston SL, Booker C, Kramer P, Dodson WC. Chronic uterine inversion at 14 weeks postpartum. Obstet Gynecol 2007; 109:555.</a></li><li><a class="nounderline abstract_t">Baskett TF. Acute uterine inversion: a review of 40 cases. J Obstet Gynaecol Can 2002; 24:953.</a></li><li><a class="nounderline abstract_t">Witteveen T, van Stralen G, Zwart J, van Roosmalen J. Puerperal uterine inversion in the Netherlands: a nationwide cohort study. Acta Obstet Gynecol Scand 2013; 92:334.</a></li><li><a class="nounderline abstract_t">Deneux-Tharaux C, Sentilhes L, Maillard F, et al. Effect of routine controlled cord traction as part of the active management of the third stage of labour on postpartum haemorrhage: multicentre randomised controlled trial (TRACOR). BMJ 2013; 346:f1541.</a></li><li><a class="nounderline abstract_t">Rudloff U, Joels LA, Marshall N. Inversion of the uterus at caesarean section. Arch Gynecol Obstet 2004; 269:224.</a></li><li><a class="nounderline abstract_t">Beringer RM, Patteril M. Puerperal uterine inversion and shock. Br J Anaesth 2004; 92:439.</a></li><li><a class="nounderline abstract_t">Hsieh TT, Lee JD. Sonographic findings in acute puerperal uterine inversion. J Clin Ultrasound 1991; 19:306.</a></li><li><a class="nounderline abstract_t">Momin AA, Saifi SG, Pethani NR, Mitha SH. Sonography of postpartum uterine inversion from acute to chronic stage. J Clin Ultrasound 2009; 37:53.</a></li><li><a class="nounderline abstract_t">Huntington JL, Irving FC, Kellogg FS. Abdominal reposition in acute inversion of the puerperal uterus. Am J Obstet Gynecol 1928; 15:34.</a></li><li><a class="nounderline abstract_t">Brar HS, Greenspoon JS, Platt LD, Paul RH. Acute puerperal uterine inversion. New approaches to management. J Reprod Med 1989; 34:173.</a></li><li><a class="nounderline abstract_t">Smith GN, Brien JF. Use of nitroglycerin for uterine relaxation. Obstet Gynecol Surv 1998; 53:559.</a></li><li><a class="nounderline abstract_t">Dayan SS, Schwalbe SS. The use of small-dose intravenous nitroglycerin in a case of uterine inversion. Anesth Analg 1996; 82:1091.</a></li><li><a class="nounderline abstract_t">Yoo KY, Lee JC, Yoon MH, et al. The effects of volatile anesthetics on spontaneous contractility of isolated human pregnant uterine muscle: a comparison among sevoflurane, desflurane, isoflurane, and halothane. Anesth Analg 2006; 103:443.</a></li><li class="breakAll">Huntington JL. Acute inversion of the uterus. Boston Medical and Surgical Journal 1921; 184:376.</li><li><a class="nounderline abstract_t">Haultain FW. Abdominal Hysterotomy for Chronic Uterine Inversion. Proc R Soc Med 1908; 1:279.</a></li><li><a class="nounderline abstract_t">Haultain FWN. Abdominal hysterotomy for chronic uterine inversion: a record of three cases. Edinburgh Med J 1908; 1:528.</a></li><li><a class="nounderline abstract_t">Momani AW, Hassan A. Treatment of puerperal uterine inversion by the hydrostatic method; reports of five cases. Eur J Obstet Gynecol Reprod Biol 1989; 32:281.</a></li><li><a class="nounderline abstract_t">Ogueh O, Ayida G. Acute uterine inversion: a new technique of hydrostatic replacement. Br J Obstet Gynaecol 1997; 104:951.</a></li><li><a class="nounderline abstract_t">Tan KH, Luddin NS. Hydrostatic reduction of acute uterine inversion. Int J Gynaecol Obstet 2005; 91:63.</a></li><li><a class="nounderline abstract_t">Vijayaraghavan R, Sujatha Y. Acute postpartum uterine inversion with haemorrhagic shock: laparoscopic reduction: a new method of management? BJOG 2006; 113:1100.</a></li><li><a class="nounderline abstract_t">Sardeshpande NS, Sawant RM, Sardeshpande SN, Sabnis SD. Laparoscopic correction of chronic uterine inversion. J Minim Invasive Gynecol 2009; 16:646.</a></li><li><a class="nounderline abstract_t">Shepherd LJ, Shenassa H, Singh SS. Laparoscopic management of uterine inversion. J Minim Invasive Gynecol 2010; 17:255.</a></li><li><a class="nounderline abstract_t">Antonelli E, Irion O, Tolck P, Morales M. Subacute uterine inversion: description of a novel replacement technique using the obstetric ventouse. BJOG 2006; 113:846.</a></li><li><a class="nounderline abstract_t">You WB, Zahn CM. Postpartum hemorrhage: abnormally adherent placenta, uterine inversion, and puerperal hematomas. Clin Obstet Gynecol 2006; 49:184.</a></li><li><a class="nounderline abstract_t">Watson P, Besch N, Bowes WA Jr. Management of acute and subacute puerperal inversion of the uterus. Obstet Gynecol 1980; 55:12.</a></li><li><a class="nounderline abstract_t">Kitchin JD 3rd, Thiagarajah S, May HV Jr, Thornton WN Jr. Puerperal inversion of the uterus. Am J Obstet Gynecol 1975; 123:51.</a></li><li><a class="nounderline abstract_t">Platt LD, Druzin ML. Acute puerperal inversion of the uterus. Am J Obstet Gynecol 1981; 141:187.</a></li><li><a class="nounderline abstract_t">Adesiyun AG. Septic postpartum uterine inversion. Singapore Med J 2007; 48:943.</a></li><li><a class="nounderline abstract_t">O'Connor M. Uterine inversion. J Am Board Fam Pract 2000; 13:385.</a></li><li><a class="nounderline abstract_t">Mahatme S, Badhwar VR, Gandi S. Subacute uterine inversion--an interesting encounter. J Indian Med Assoc 2010; 108:378.</a></li><li><a class="nounderline abstract_t">Garrett-Albaugh S, Stitely ML, Millan L, Hochberg C. Chronic postpartum uterine inversion treated by abdominal replacement and cerclage. W V Med J 2011; 107:43.</a></li><li><a class="nounderline abstract_t">Soleymani Majd H, Pilsniak A, Reginald PW. Recurrent uterine inversion: a novel treatment approach using SOS Bakri balloon. BJOG 2009; 116:999.</a></li><li><a class="nounderline abstract_t">Mondal PC, Ghosh D, Santra D, et al. Role of Hayman technique and its modification in recurrent puerperal uterine inversion. J Obstet Gynaecol Res 2012; 38:438.</a></li><li><a class="nounderline abstract_t">Matsubara S, Yano H, Taneichi A, Suzuki M. Uterine compression suture against impending recurrence of uterine inversion immediately after laparotomy repositioning. J Obstet Gynaecol Res 2009; 35:819.</a></li><li><a class="nounderline abstract_t">Matsubara S, Baba Y. MY (Matsubara-Yano) uterine compression suture to prevent acute recurrence of uterine inversion. Acta Obstet Gynecol Scand 2013; 92:734.</a></li></ol></div><div id="topicVersionRevision">Topic 4458 Version 28.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9255049" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Puerperal inversion of the uterus in Nepal: case reports and review of literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15885762" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Non-puerperal uterine inversion in association with uterine sarcoma: case report in a 26-year-old and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17666639" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Nonpuerperal uterine inversion associated with an immature teratoma of the uterus in an adolescent.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22377482" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Uterine inversion in association with uterine sarcoma: a case report with MRI findings and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22122794" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Ultrasound diagnosis of complete uterine inversion in a nulliparous woman.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20597092" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Ultrasonographic diagnosis of incomplete uterine inversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28522320" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Risks and consequences of puerperal uterine inversion in the United States, 2004 through 2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3350199" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Puerperal inversion of the uterus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10764194" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Uterine inversion: a life-threatening obstetric emergency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8015697" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : [Acute puerperal uterine inversion: a report of 3 cases and an analysis of 358 cases in the literature].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17267893" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Chronic uterine inversion at 14 weeks postpartum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12464994" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Acute uterine inversion: a review of 40 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22881867" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Puerperal uterine inversion in the Netherlands: a nationwide cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23538918" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Effect of routine controlled cord traction as part of the active management of the third stage of labour on postpartum haemorrhage: multicentre randomised controlled trial (TRACOR).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14634756" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Inversion of the uterus at caesarean section.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14970137" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Puerperal uterine inversion and shock.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1651349" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Sonographic findings in acute puerperal uterine inversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18855933" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Sonography of postpartum uterine inversion from acute to chronic stage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Abdominal reposition in acute inversion of the puerperal uterus</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2926734" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Acute puerperal uterine inversion. New approaches to management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9751938" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Use of nitroglycerin for uterine relaxation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8610877" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The use of small-dose intravenous nitroglycerin in a case of uterine inversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16861431" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : The effects of volatile anesthetics on spontaneous contractility of isolated human pregnant uterine muscle: a comparison among sevoflurane, desflurane, isoflurane, and halothane.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16861431" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : The effects of volatile anesthetics on spontaneous contractility of isolated human pregnant uterine muscle: a comparison among sevoflurane, desflurane, isoflurane, and halothane.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19973204" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Abdominal Hysterotomy for Chronic Uterine Inversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Abdominal hysterotomy for chronic uterine inversion: a record of three cases</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2792548" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Treatment of puerperal uterine inversion by the hydrostatic method; reports of five cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9255090" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Acute uterine inversion: a new technique of hydrostatic replacement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16040034" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Hydrostatic reduction of acute uterine inversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16956343" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Acute postpartum uterine inversion with haemorrhagic shock: laparoscopic reduction: a new method of management?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19835813" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Laparoscopic correction of chronic uterine inversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20226420" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Laparoscopic management of uterine inversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16827772" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Subacute uterine inversion: description of a novel replacement technique using the obstetric ventouse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16456355" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Postpartum hemorrhage: abnormally adherent placenta, uterine inversion, and puerperal hematomas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7352052" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Management of acute and subacute puerperal inversion of the uterus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1180283" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Puerperal inversion of the uterus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7282793" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Acute puerperal inversion of the uterus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17909681" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Septic postpartum uterine inversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11001015" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Uterine inversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21121391" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Subacute uterine inversion--an interesting encounter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22034809" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Chronic postpartum uterine inversion treated by abdominal replacement and cerclage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19522802" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Recurrent uterine inversion: a novel treatment approach using SOS Bakri balloon.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22379624" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Role of Hayman technique and its modification in recurrent puerperal uterine inversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19751352" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Uterine compression suture against impending recurrence of uterine inversion immediately after laparotomy repositioning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22881712" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : MY (Matsubara-Yano) uterine compression suture to prevent acute recurrence of uterine inversion.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
